Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 319 1. Ahn Kook PHARM 1. Company Information Company Ahn Kook PHARM Representative Joon-Sun, Eo E-mail agoverseas@ahn-gook.com Representative Phone No. Hompage Address Research Institute Address Year of Establishment The Number of Employees (06‘) 080-3289-4200 http://www.ahn-gook.com/ Representative Fax No. 993-75 Daelim-dong youngdungpo-gu Seoul 080-847-8869 903-2 Sangsin-ri Hyangnam-myun Hwaseong-si kyunggi-do 1955 Sales (‘06) 61.1 Million$ Total The Number of 310 Researcher (‘06) 17 Total Contact Person Jeong-Hun, Han Contact Phone 82-2-3289-4259 Contact E-mail hjh@ahn-gook.com Contact Fax 82-2-849-4123 Introduction of Company With the faith and determination embodied in the statement of "To pursue and realize the health and happiness of the human race by developing great pharmaceutical products", Ahn-gook Pharmaceutical firm has never ceased doing its best, registering in the KOSDAQ in 2001 for the transparent management and proving itself the backbone of the Korean pharmaceutical industry. We've been through ups and downs and overcome many challenges for the last 40 years, still delivering our services to you till now. Nothing of these would have been possible without your concern and love for us. And we are well aware that the only way to pay back your love and expectation is to always go forward at the full power to become more solid and capable by developing new products of new treatment methods and actively marketing. The new and better future of Ahn-gook is dependent on your constant concern, encouragement and kind advice. And I wish this homepage will avail itself as the place where you and Ahn-gook Pharmaceutical will get together and interact. Thank you very much
320 2007 Korea Pharmaceutical Industry Directory 2. Main Products Information No. The Name of Products Main Ingredient Use (Indications) Formulation The Date of Sales Expected Exporting Countries Etc. 1 GRANDPAZE Mg.Aluminometasilicate Overeating, Dyspepsia TABLET 2 TOBICOM Vaccinium myrtillus ext Asthenopia, Visual disturbance TABLET 3 PROCETIN Fluoxetine HCL Depression CAPSULE 4 CONTRO Sodium chondroitin sulfate Arthralgia, Articular neuralgia CAPSULE 5 HEMOGOLD Carbonyl Iron Iron deficiency anemia TABLET 6 ANYFEN Dexibuprofen Chronic multiple arthritis TABLET 7 RAFERON tablet contains; Microencapsulated Acetaminophen Headache, Myalgia TABLET 8 TATANAL Ibuprofen Fever TABLET 9 ACEFENAC Aceclofenac Osteoarthritis, Scapula periarthritis TABLET 10 KIDFEN Pranoprofen Antipyretic for acute upper respiratory infection SYRUP 3. R&D Figures Pre-clinical Clinical Marketed Prospan®(Bronchitis) Tobicom®/Tobicom-S®(Eye Nutrient) Anyfen®(Inflammation/Fever) Hemogold(Anemia) Emitasol®(Emesis) Immucothel®(Immuno-modulator)
Page 2 and 3: 2007 Korea Pharmaceutical Industry
Page 4 and 5: 2007 Korea Pharmaceutical Industry
Page 6 and 7: 27. ILYANG PHARM ·········
Page 8 and 9: Chapter 1. Outline of The Project 2
Page 10 and 11: Chapter 1. Outline of The Project 2
Page 12 and 13: Chapter 2. Pharmaceutical Industry
Page 36 and 37: The Annex
Page 38 and 39: 316 2007 Korea Pharmaceutical Indus
Page 42 and 43: The Korean Pharmaceutical Company L
Page 72 and 73: 4. Company Map The Korean Pharmace
Page 88 and 89: 5. Company Map The Korean Pharmace
Page 90 and 91:
The Korean Pharmaceutical Company L
Page 92 and 93:
5. Company Map The Korean Pharmace
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

Create successful ePaper yourself

Delete template?

Save as template?